{"id":2923,"date":"2026-08-26T00:44:45","date_gmt":"2026-08-25T23:44:45","guid":{"rendered":"https:\/\/officialcorepeptides.brandloom.net\/it\/?post_type=product&p=2923"},"modified":"2026-08-26T00:44:45","modified_gmt":"2026-08-25T23:44:45","slug":"buy-pancragen-20mg-in-switzerland","status":"publish","type":"product","link":"https:\/\/officialcorepeptides.ch\/it\/product\/buy-pancragen-20mg-in-switzerland\/","title":{"rendered":"Pancragen (20MG)"},"content":{"rendered":"

What Is Pancragen?<\/h2>\n

Pancragen is a synthetic tetrapeptide bioregulator with the amino acid sequence Lys-Glu-Asp-Trp (KEDW). It belongs to the Khavinson peptide series a family of short-chain peptides developed through research on tissue-specific bioregulators. Originally identified from peptide fractions isolated from bovine pancreatic tissue, Pancragen represents a targeted approach to investigating pancreatic cell biology and function.<\/p>\n

As a tetrapeptide a peptide composed of exactly four amino acids Pancragen has attracted research interest for its potential to interact with nuclear structures such as DNA and histones, supporting gene transcription and cellular differentiation in pancreatic cells. Researchers classify Pancragen as a peptide bioregulator, meaning it may influence cellular processes through epigenetic and transcriptional mechanisms rather than through classical receptor-mediated signaling. For those looking to buy Pancragen 20mg in Switzerland<\/strong>, Core Peptides offers high-quality research-grade material for laboratory applications.<\/p>\n

Pancragen Research Overview<\/h2>\n

Pancragen represents a well-documented peptide bioregulator within the Khavinson research program. The peptide’s design a simple tetrapeptide sequence of lysine, glutamic acid, aspartic acid, and tryptophan belies its complex biological activity. Researchers have investigated Pancragen primarily for its tissue-specific effects on pancreatic cells, with implications for understanding pancreatic function, glucose metabolism, and age-associated metabolic processes.<\/p>\n

Research interest in Pancragen centers on its ability to stimulate the expression of differentiation factors in both acinar and islet pancreatic cells. Studies have demonstrated that Pancragen influences the expression of critical transcription factors including PDX1, PAX6, PAX4, FOXA2, and NKX2.2 genes essential for pancreatic cell development and function. Consequently, Pancragen has generated significant interest as a research tool for investigating pancreatic biology, diabetes mechanisms, and age-related metabolic decline.<\/p>\n

When researchers choose to buy Pancragen 20mg in Switzerland<\/strong> for laboratory studies, they gain access to a compound that may help elucidate mechanisms of pancreatic cell differentiation, glucose regulation, and metabolic homeostasis at the molecular level.<\/p>\n

How Does Pancragen Work?<\/h2>\n

The proposed mechanism of Pancragen involves direct nuclear interactions and epigenetic regulation of pancreatic gene expression. Researchers believe Pancragen can penetrate cellular membranes to reach the nucleus, where it interacts with DNA and histones to modulate transcriptional activity.<\/p>\n

Transcriptional Regulation of Pancreatic Genes<\/h3>\n

Studies have shown that Pancragen upregulates critical development genes controlling pancreatic cell maturation and function. Specifically, research has documented increased expression of PDX1 (1.6-fold), NGN3 (2.7-fold), and PAX6 (1.8-fold) following Pancragen treatment. These transcription factors play essential roles in pancreatic development, beta-cell differentiation, and maintenance of pancreatic islet function.<\/p>\n

Furthermore, Pancragen stimulates the expression of differentiation factors in both acinar cells (PDX1, PTF1A) and islet cells (PDX1, PAX6, PAX4, FOXA2, NKX2.2). This tissue-specific stimulation suggests that Pancragen may influence both the exocrine and endocrine functions of the pancreas through coordinated transcriptional regulation.<\/p>\n

Epigenetic Mechanisms<\/h3>\n

Investigations suggest that Pancragen may regulate intracellular signaling and epigenetic pathways governing cellular aging and functional maintenance. By interacting with nuclear structures, Pancragen may influence gene expression patterns that support pancreatic cell health and function, particularly in the context of age-related decline.<\/p>\n

Researchers who buy Pancragen 20mg in Switzerland<\/strong> for research purposes can investigate these mechanisms across diverse experimental models.<\/p>\n

Why Is Pancragen Studied?<\/h2>\n

Researchers study Pancragen primarily for its potential relevance to pancreatic biology, glucose metabolism, and age-related metabolic dysfunction. The peptide’s ability to influence pancreatic cell differentiation and gene expression makes it a valuable tool for understanding the molecular basis of pancreatic function and metabolic regulation.<\/p>\n

The peptide’s tissue-specific effects on pancreatic cells have made it a focus of diabetes and metabolic research. Preclinical studies have explored Pancragen’s effects on glucose metabolism, insulin sensitivity, and pancreatic islet function in various experimental models, including streptozotocin-induced diabetes in rats and age-related glucose intolerance in non-human primates.<\/p>\n

Moreover, researchers study Pancragen in the context of age-related metabolic decline. As pancreatic function naturally diminishes with age, understanding mechanisms that support pancreatic health has become increasingly important. Pancragen represents one well-documented avenue of research inquiry in this area.<\/p>\n

Researchers who buy Pancragen 20mg in Switzerland<\/strong> from Core Peptides can incorporate this peptide into their studies on pancreatic cell differentiation, glucose metabolism, insulin sensitivity, and age-related metabolic research.<\/p>\n

Pancragen Research Areas<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n
Research Area<\/th>\nDescription<\/th>\n<\/tr>\n<\/thead>\n
Pancreatic Cell Differentiation<\/strong><\/td>\nInvestigating Pancragen’s potential to stimulate differentiation of acinar and islet pancreatic cells<\/td>\n<\/tr>\n
Glucose Metabolism<\/strong><\/td>\nStudying Pancragen’s effects on blood glucose levels and glucose tolerance<\/td>\n<\/tr>\n
Insulin Sensitivity<\/strong><\/td>\nExamining Pancragen’s influence on insulin production, secretion, and sensitivity<\/td>\n<\/tr>\n
Transcriptional Regulation<\/strong><\/td>\nExploring Pancragen’s effects on pancreatic gene expression (PDX1, PAX6, NGN3, etc.)<\/td>\n<\/tr>\n
Epigenetic Research<\/strong><\/td>\nInvestigating Pancragen’s interaction with DNA, histones, and epigenetic mechanisms<\/td>\n<\/tr>\n
Beta-Cell Health<\/strong><\/td>\nPreclinical research into Pancragen’s potential to support pancreatic beta-cell function<\/td>\n<\/tr>\n
Age-Related Metabolic Research<\/strong><\/td>\nStudying Pancragen’s effects on age-related decline in pancreatic function<\/td>\n<\/tr>\n
Diabetes Research<\/strong><\/td>\nExploring Pancragen’s potential relevance to glucose regulation and insulin resistance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Scientific Research on Pancragen<\/h2>\n

Researchers have conducted scientific studies on Pancragen in both in vitro and in vivo settings, deriving evidence from cell cultures, rodent models, and non-human primate studies. The peptide originates from the Khavinson research program, which has investigated tissue-specific peptide bioregulators for several decades.<\/p>\n

In Vitro Evidence<\/h3>\n

In vitro studies have demonstrated that Pancragen stimulates the expression of differentiation factors in pancreatic cell cultures. Research has shown that Pancragen upregulates PDX1 (1.6-fold), NGN3 (2.7-fold), and PAX6 (1.8-fold), genes critical for pancreatic cell maturation and function. Additionally, Pancragen stimulates differentiation factors in both acinar cells (PDX1, PTF1A) and islet cells (PDX1, PAX6, PAX4, FOXA2, NKX2.2). These findings suggest that Pancragen may influence both the exocrine and endocrine functions of the pancreas.<\/p>\n

Preclinical Animal Studies<\/h3>\n

In rodent models, researchers have investigated Pancragen’s effects on glucose metabolism. A study in Wistar rats with experimental streptozotocin-induced diabetes mellitus found that oral Pancragen produced a pronounced hypoglycemic effect during treatment. Intramuscular administration of Pancragen normalized the adhesion of mesenteric capillary endothelium.<\/p>\n

Furthermore, research has explored Pancragen’s tissue-specific effects in organotypic tissue cultures. Studies using explants from the pancreas of young and aged rats demonstrated that Pancragen showed a stimulating effect in appropriate tissue cultures.<\/p>\n

Non-Human Primate Studies<\/h3>\n

Two primate studies provide some of the strongest preclinical evidence for Pancragen. A 2015 study administered Pancragen to aged female rhesus monkeys (20\u201325 years old) and demonstrated reductions in fasting blood glucose levels and normalization of insulin and C-peptide values, suggesting restoration of age-related glucose intolerance.<\/p>\n

Researchers concluded that Pancragen is effective and safe for correcting age-related imbalances in endocrine pancreatic function and may have potential for addressing age-related dysfunction of the pancreatic islet apparatus.<\/p>\n

Human Research<\/h3>\n

Pancragen has limited human clinical evidence. Of 8 total research sources identified, only one human study with no randomized controlled trials has been documented. Available evidence primarily derives from in vitro and animal research. Findings should be interpreted as experimental rather than established. Scientists who buy Pancragen 20mg in Switzerland<\/strong> should remain aware of these evidence considerations.<\/p>\n

Pancragen Compared With Related Peptides<\/h2>\n\n\n\n\n\n\n\n\n\n
Peptide<\/th>\nRelationship to Pancragen<\/th>\nKey Differences<\/th>\n<\/tr>\n<\/thead>\n
Bronchogen<\/strong><\/td>\nSame Khavinson peptide series, different tissue target<\/td>\nBronchogen (Ala-Glu-Asp-Leu) targets bronchial epithelial cells; Pancragen targets pancreatic cells<\/td>\n<\/tr>\n
Vesugen<\/strong><\/td>\nSame Khavinson peptide series, different tissue target<\/td>\nVesugen (Lys-Glu-Asp) targets fibroblasts; Pancragen (Lys-Glu-Asp-Trp) targets pancreatic cells<\/td>\n<\/tr>\n
Livagen<\/strong><\/td>\nSame Khavinson peptide series<\/td>\nLivagen targets liver tissue; Pancragen targets pancreatic tissue<\/td>\n<\/tr>\n
Pinealon<\/strong><\/td>\nSame Khavinson peptide series<\/td>\nPinealon targets pineal gland; Pancragen targets pancreas<\/td>\n<\/tr>\n
Testagen<\/strong><\/td>\nSame Khavinson peptide series<\/td>\nTestagen targets testicular tissue; Pancragen targets pancreatic tissue<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Research Applications<\/h2>\n

Researchers utilize Pancragen in a variety of laboratory research applications, primarily in the fields of pancreatic biology, metabolism, and endocrinology. Key research applications include:<\/p>\n